TRANS4M was founded with a singular purpose: to redefine the landscape of longevity through hyper-personalised, data-driven medicine. Explore how we’ve evolved from our early vision into a leading facility for proactive health.
A History of Evolution
2018
Founding the Vision
TRANS4M was established with a focus on comprehensive hormonal health and restorative medicine, laying the foundation for our core clinical values and patient-first approach.
2020
Embracing Precision Data
We expanded our clinical protocols to integrate advanced biomarker testing and precision analytics, allowing for truly individualised age-optimisation treatments rather than standard reactive care.
2022
Launched Telemedicine
To make proactive healthcare more accessible, we introduced our secure telemedicine platform and partnered with specialised compounding pharmacies for seamless home delivery of prescribed therapeutics.
2024
Longevity Facility of Choice
Today, TRANS4M stands as a premier destination for performance health, continuously innovating our protocols and expanding our multidisciplinary team to support a growing community of optimised individuals.
LEADERSHIP VISION
Meet Our Medical Directors
Dr. Sarah Jansen, MD
Longevity Medicine Lead
Dr. Jansen focuses on advanced hormonal health and age optimisation protocols. With over 15 years of clinical experience, she is dedicated to transitioning patients from reactive treatments to proactive, preventative care.
Dr. Michael Chen, MD
Hormonal Health Specialist
Dr. Chen specialises in metabolic function and personalised therapeutic interventions. He brings over 15 years of specialised expertise to our precision medicine programmes, ensuring data-backed results for every patient.